Skip to main content

Table 1 Clinical characteristic of three groups (WGE = week of gestational age)

From: Re-comparing of three different epidemic seasons of bronchiolitis: different prophylaxis approaches

 

S1 (2015–2016)

S2 (2016–2017)

S3 (2017–2018)

P value*

Newborn with WGE 30+ 0–32+ 6

35

47

56

 

Mean gestational age

30,9

31

31,5

 

Newborn with WGE < 31 sett (30+ 0–30+ 6)

16/35 (45,7%)

18/47 (38,3%)

16/56 (28,57%)

P = 0.29

Newborn treated with PLV

27

2

56

P < 0,00001

Number of bronchiolitis

6/35 (17%)

12/47 (26%)

6/56 (10,7%)

P =0.048

Hospitalized for bronchiolitis

3/6 (50%)

6/12 (50%)

3a/6 (50%)

P = 1

Absolute percentage of admissions

3/35 (8,6%)

6/47 (12,8%)

3/56 (5,3%)

P =0.184

Intubation at birth

3/3 (100%)

4/6 (66,7%)

0/3 (0%)

P = 0,16

Age at the admission (Months)

7

4.3

3b

 

Intubation at admission

1/3 (33,3%)

2/6 (33,3%)

1c/3 (33,3%)

P = 1

  1. *all statistical analysis was performed comparing S2 with S3
  2. aAll 3 preterm had received only one dose of palivizumab before having bronchiolitis
  3. bAll 3 preterm had received only one dose of palivizumab before having bronchiolitis and were born in full epidemic season
  4. cnewborn who had received only one dose of palivizumab